Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rankning i aktier #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aktiekurs
$1.05
Senast synkroniserad: 2026-08-19
Marknadsvärde
$25.12M
Förändring (1 dag)
0.00%
Förändring (1 år)
-86.33%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Kategori

Historik för aktiesplit för Actuate Therapeutics Inc (ACTU)
Aktien Actuate Therapeutics Inc (symbol: ACTU) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En ACTU-aktie köpt före Aug 20, 2026 motsvarar nu 0 ACTU-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH